ID   UKRV-Mel-20c
AC   CVCL_C402
DR   cancercelllines; CVCL_C402
DR   Cosmic; 1846711
DR   Cosmic; 2686524
DR   ESTDAB; ESTDAB-234
DR   Wikidata; Q54990611
RX   PubMed=23348503;
RX   PubMed=26909863;
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Heterozygous (PubMed=26909863).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1788; CDKN2B; Zygosity=Heterozygous (PubMed=26909863).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7413; MTAP + HGNC; HGNC:34341; CDKN2B-AS1; Name(s)=MTAP-ANRIL (PubMed=26909863).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Arg (c.182A>G); ClinVar=VCV000013900; Zygosity=Unspecified (PubMed=23348503).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-146C>T (c.250C>T) (C250T); Zygosity=Unspecified; Note=In promoter (PubMed=23348503).
ST   Source(s): ESTDAB=ESTDAB-234
ST   Amelogenin: X,Y
ST   CSF1PO: 13
ST   D13S317: 12
ST   D3S1358: 16,17
ST   D5S818: 12,14
ST   D7S820: 10,12
ST   FGA: 21,25
ST   TH01: 7,9
ST   TPOX: 8
ST   vWA: 16,19
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A721 ! UKRV-Mel-20a
OI   CVCL_C401 ! UKRV-Mel-20b
OI   CVCL_C403 ! UKRV-Mel-20e
OI   CVCL_C404 ! UKRV-Mel-20f
OI   CVCL_C405 ! UKRV-Mel-20h
SX   Male
AG   27Y
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 19-12-24; Version: 15
//
RX   PubMed=23348503; DOI=10.1126/science.1230062;
RA   Horn S., Figl A., Rachakonda P.S., Fischer C., Sucker A., Gast A.,
RA   Kadel S., Moll I., Nagore E., Hemminki K., Schadendorf D., Kumar R.;
RT   "TERT promoter mutations in familial and sporadic melanoma.";
RL   Science 339:959-961(2013).
//
RX   PubMed=26909863; DOI=10.18632/oncotarget.7503; PMCID=PMC4941330;
RA   Xie H.-P., Rachakonda P.S., Heidenreich B., Nagore E., Sucker A.,
RA   Hemminki K., Schadendorf D., Kumar R.;
RT   "Mapping of deletion breakpoints at the CDKN2A locus in melanoma:
RT   detection of MTAP-ANRIL fusion transcripts.";
RL   Oncotarget 7:16490-16504(2016).
//